Funded Tech Companies

Fore Biotherapeutics

Fore Biotherapeutics is a biopharmaceutical company, based in Philadelphia. Financial backing was provided by SR One Capital Management, HBM Healthcare Investments and Symbiosis.

Company Overview

Contact Information

Company Background Information

Overview

We are a precision oncology company using functional genomics to pioneer treatments that improve the lives of patients with rare cancers. Fore Bio is a next-generation precision oncology company. Using our functional genomics platform, we are hyper-targeting therapies to unaddressed tumor mutations to benefit patients with few therapeutic alternatives. Our mission is to provide "1-to-1" matching between patients and new treatments tailored to them and providing broad access with speed and quality.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/8/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Matthew Ros

        

Chief Financial Officer

Jeff Sacher

        

Chief Medical Officer

Stacie Shepherd

        

Chief Technical Officer

Gabi Tarcic

        

Company Investors

• SR One Capital Management
• HBM Healthcare Investments
• Symbiosis
• Novartis Venture Fund
• OrbiMed
• Windham Venture Partners
• TaiAx Life Science Fund
• Wellington Management Company
• 3B Future Health Fund
• Axil Capital
• Samsung Securities
• Medicxi Ventures (Giovanni Mariggi)
• LG Technology Venture
• Primer Sazze Partners
• Cormorant Asset Management

Browse more funded tech companies:

Fordefi | Forecast

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary